Literature DB >> 9232449

A case of primary immunodeficiency due to a defect of the major histocompatibility gene complex class I processing and presentation pathway.

H Teisserenc1, W Schmitt, N Blake, R Dunbar, S Gadola, W L Gross, A Exley, V Cerundolo.   

Abstract

INTRODUCTION: We report a case of primary immunodeficiency due to a defect of the TAP transporter, an heterodimeric complex which controls the expression of HLA class I molecule by delivering peptides from the cytosol into the lumen of the endoplasmic reticulum. Since childhood, the 36 year old female suffered from recurrent sinusitis/bronchitis. She later developed bronchiectasis and destructive nasal epitheloid granulomata in conjunction with a generalized vasculitic syndrome that did not improve upon immunosuppression and antibiotics.
METHODS: The class I monomorphic W6/32 was used for cell surface staining and immunoprecipitation of MHC class I molecules. Peptide transport assay was carried out in semi-permeabilized cells with iodinated peptides. Antigen presentation experiments were performed using chromium 51 labelled patient B cell line and EBV specific CTL. TAP1 and TAP2 specific antibodies were used for Western blotting and immunoprecipitation of the TAP complex. RESULTS AND
CONCLUSIONS: A severe reduction of MHC class I molecules at the cell surface of the B-cell lines was observed, whereas MHC class II expression was not altered. Isoelectric focusing of metabolically labelled MHC class I molecules revealed that class I heavy chains remain unsialylated, consistent with a block of TAP dependent peptide translocation. These conclusions were confirmed by further experiments showing that peptide translocation was completely abolished. We also demonstrated that presentation of viral antigens through endogenous class I molecules was severely impaired. Immunoprecipitation and Western blotting of TAP1/2 complex showed that TAP2 was not detectable. Further, experiments are in progress to identify the site of the mutation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9232449     DOI: 10.1016/s0165-2478(97)00072-2

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  9 in total

Review 1.  TAP deficiency syndrome.

Authors:  S D Gadola; H T Moins-Teisserenc; J Trowsdale; W L Gross; V Cerundolo
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

2.  Molecular studies and NK cell function of a new case of TAP2 homozygous human deficiency.

Authors:  N Matamoros; J Milà; M Llano; A Balas; J L Vicario; J Pons; C Crespí; N Martinez; J Iglesias-Alzueta; M López-Botet
Journal:  Clin Exp Immunol       Date:  2001-08       Impact factor: 4.330

3.  Interferon regulatory factor 7 mediates activation of Tap-2 by Epstein-Barr virus latent membrane protein 1.

Authors:  L Zhang; J S Pagano
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

4.  HLA class I deficiencies due to mutations in subunit 1 of the peptide transporter TAP1.

Authors:  H de la Salle; J Zimmer; D Fricker; C Angenieux; J P Cazenave; M Okubo; H Maeda; A Plebani; M M Tongio; A Dormoy; D Hanau
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

5.  Splice acceptor site mutation of the transporter associated with antigen processing-1 gene in human bare lymphocyte syndrome.

Authors:  H Furukawa; S Murata; T Yabe; N Shimbara; N Keicho; K Kashiwase; K Watanabe; Y Ishikawa; T Akaza; K Tadokoro; S Tohma; T Inoue; K Tokunaga; K Yamamoto; K Tanaka; T Juji
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

6.  BPI-ANCA in transporter associated with antigen presentation (TAP) deficiency: possible role in susceptibility to Gram-negative bacterial infections.

Authors:  H Schultz; S Schinke; J Weiss; V Cerundolo; W L Gross; S Gadola
Journal:  Clin Exp Immunol       Date:  2003-08       Impact factor: 4.330

7.  A case-control study on association of proteasome subunit beta 8 (PSMB8) and transporter associated with antigen processing 1 (TAP1) polymorphisms and their transcript levels in vitiligo from Gujarat.

Authors:  Shahnawaz D Jadeja; Mohmmad Shoab Mansuri; Mala Singh; Mitesh Dwivedi; Naresh C Laddha; Rasheedunnisa Begum
Journal:  PLoS One       Date:  2017-07-10       Impact factor: 3.240

Review 8.  Viruses, cancer and non-self recognition.

Authors:  Monikaben Padariya; Umesh Kalathiya; Sara Mikac; Katarzyna Dziubek; Maria C Tovar Fernandez; Ewa Sroka; Robin Fahraeus; Alicja Sznarkowska
Journal:  Open Biol       Date:  2021-03-31       Impact factor: 6.411

9.  Variations in TAP1 and PSMB9 Genes Involved in Antigen Processing and Presentation Increase the Risk of Vitiligo in the Saudi Community.

Authors:  Ahmad H Mufti; Imad A AlJahdali; Nasser A Elhawary; Samar N Ekram; Iman Abumansour; Ikhlas A Sindi; Hind Naffadi; Ezzeldin N Elhawary; Najiah M Alyamani; Ghydda Alghamdi; Wafaa Alosaimi; Ghufran Rawas; Amaal Alharbi; Mohammed T Tayeb
Journal:  Int J Gen Med       Date:  2021-12-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.